Keyphrases
Immunogenicity
100%
Antigen-specific
100%
Human Dendritic Cells
100%
Dendritic Cells
100%
Tumor Antigen
100%
IL-12 Production
100%
Sequential Delivery
100%
Effector T Cells
28%
Interleukin-12 (IL-12)
21%
Antigen Presentation
21%
MART
21%
ELISPOT
14%
ELISpot Assay
14%
Cell-to-cell
14%
Costimulatory Molecules
14%
MRNA Transfection
14%
Soluble CD40 Ligand
14%
M1 Matrix Protein
14%
Cancer Treatment
7%
Fold Increase
7%
Specific T Cells
7%
Cell Surface
7%
Clinical Trials
7%
Cell Surface Markers
7%
Vaccine Strategy
7%
Influenza
7%
Immature Dendritic Cells
7%
CD40
7%
CD80
7%
CD86
7%
Monocyte-derived Dendritic Cells (MoDCs)
7%
Naïve T Cells
7%
Cell Preparation
7%
Surface Expression
7%
Specific Antigen
7%
CD8+
7%
Dendritic Cell Vaccine
7%
RNA-based
7%
Anti-melanoma
7%
MART-1
7%
T Cell Clone
7%
Dendritic Cell Maturation
7%
Melanoma Antigens
7%
First Maturation
7%
Optimal Mean
7%
Sequential Addition
7%
Medicine and Dentistry
Maturation
100%
Immunogenicity
100%
Dendritic Cell
100%
Tumor Antigen
100%
T Cell
33%
Antigen Specificity
22%
Secretion (Process)
16%
Antigen Presentation
16%
Messenger RNA
16%
In Vitro
11%
Cell Surface
11%
Genetic Transfection
11%
CD40 Ligand
11%
Cancer Treatment
5%
Clinical Trial
5%
Cell Surface Marker
5%
Cell Maturation
5%
CD8 Antigen
5%
Matrix Protein
5%
Dendritic Cell Vaccine
5%
Melanoma Antigen
5%
Melan A
5%
Immunology and Microbiology
Immunogenicity
100%
Maturation
100%
Dendritic Cell
100%
Tumor Antigen
100%
T Cell
27%
Antigen Specificity
22%
Secretion (Process)
16%
Antigen Presentation
16%
Cell Surface
11%
Genetic Transfection
11%
CD40 Ligand
11%
Cell Maturation
5%
Influenza
5%
CD80
5%
CD86
5%
Naive T Cell
5%
Matrix Protein
5%
CD8
5%
Cell Clone
5%
Melan A
5%
Dendritic Cell Vaccine
5%
Melanoma Antigen
5%
Cell Surface Marker
5%